Hindustan Bio Sciences Intrinsic Value
Hindustan Bio Sciences (HINDBIO) median intrinsic value is ₹5.00 from 1 valuation models (range ₹5–₹5), vs current price ₹7.16 — -30.2% downside (Trading Above Calculated Value), margin of safety -43.2%. See HINDBIO book value to compare market price against book value per share.
HINDBIO Valuation Methods Summary — DCF, Graham Number & P/E
Hindustan Bio Sciences intrinsic value across 1 models vs current price ₹7.16 — upside/downside and value range per method. For current market price and key ratios, visit HINDBIO share price.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹5.00 | ₹4.50 - ₹5.50 | -30.2% | Book Value/Share: ₹5.00, P/B: 1.0x |
HINDBIO Intrinsic Value vs Market Price — All Valuation Models
Hindustan Bio Sciences fair value range ₹5–₹5 vs current market price ₹7.16 across 1 valuation models. Check HINDBIO market cap trends to track the company's total market size over time.
HINDBIO Intrinsic Value Analysis — Undervalued or Overvalued?
Hindustan Bio Sciences median intrinsic value ₹5.00, current price ₹7.16 — Trading Above Calculated Value by 30.2%, margin of safety -43.2%.
What is the intrinsic value of HINDBIO?
Based on our comprehensive analysis using 1 different valuation methods, the estimated intrinsic value of Hindustan Bio Sciences (HINDBIO) is ₹5.00 (median value). With the current market price of ₹7.16, this represents a -30.2% variance from our estimated fair value.
The valuation range spans from ₹5.00 to ₹5.00, indicating ₹5.00 - ₹5.00.
Is HINDBIO undervalued or overvalued?
Based on our multi-method analysis, Hindustan Bio Sciences (HINDBIO) appears to be trading above calculated value by approximately 30.2%.
HINDBIO Financial Health — Key Ratios vs Industry Benchmarks
Hindustan Bio Sciences financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.50 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Operating Margin | 5.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
HINDBIO Cash Flow Quality — Operating & Free Cash Flow
Hindustan Bio Sciences operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-1 Cr | ₹-1 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹0 Cr | ₹0 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹1 Cr | ₹1 Cr | Positive Free Cash Flow | 8/10 |